Regulatory
IND Application
Investigational New Drug application — FDA clearance required before human trials begin.
Definition
An IND submission includes preclinical safety data, manufacturing information, and proposed trial protocols. The FDA has 30 days to place a clinical hold; if silent, the sponsor may proceed.
Related terms
Back to the full peptide glossary.